Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechSci Research | PRODUCT CODE: 1881487

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 1881487

Intensity Modulated Radiotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Radiation Type, By Application, By End User, By Region and Competition, 2020-2030F

PUBLISHED:
PAGES: 185 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4500
PDF and Excel (Multi-User License)
USD 5500
PDF and Excel (Custom Research License)
USD 8000

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

The Global Intensity Modulated Radiotherapy Market, valued at USD 2.01 Billion in 2024, is projected to experience a CAGR of 5.61% to reach USD 2.79 Billion by 2030. Intensity Modulated Radiotherapy (IMRT) is an advanced radiation therapy technique that precisely delivers radiation to tumors by modulating the intensity of numerous small radiation beams, thereby conforming to the tumor shape and minimizing exposure to surrounding healthy tissues. The market's expansion is fundamentally driven by the escalating global incidence of various cancer types, coupled with increasing demand for effective and less toxic treatment modalities that improve patient quality of life.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.01 Billion
Market Size 2030USD 2.79 Billion
CAGR 2025-20305.61%
Fastest Growing SegmentLung Cancer
Largest MarketNorth America

Key Market Drivers

The global Intensity Modulated Radiotherapy market is significantly influenced by the escalating global incidence of cancer, which fundamentally drives the demand for advanced and precise treatment modalities. The rising number of new cancer diagnoses worldwide necessitates effective therapeutic options like IMRT to manage the growing patient population. According to the American Cancer Society, in April 2024, in its "Global Cancer Statistics, 2024" report, an estimated 20 million cancer cases were newly diagnosed in 2022, underscoring the substantial and expanding need for oncology services.

Key Market Challenges

The significant capital investment required for Intensity Modulated Radiotherapy (IMRT) equipment acquisition, installation, and ongoing maintenance directly impedes the growth of the global market. This substantial financial outlay creates a considerable barrier, especially for healthcare providers in developing economies where budgets are frequently constrained. The high initial purchase price of sophisticated IMRT systems, coupled with expenses for specialized facility infrastructure, comprehensive training for technical staff, and continuous servicing contracts, places a heavy burden on healthcare systems.

Key Market Trends

The shift towards hypofractionated Intensity Modulated Radiotherapy regimens represents a significant trend in the global market, driven by its ability to deliver higher radiation doses per fraction over a shorter treatment period. This approach enhances patient convenience by reducing the number of hospital visits and overall treatment duration, while potentially lowering healthcare costs and improving access to care. According to an ASTRO 2024 report, approximately 7% of patients with intermediate-risk prostate cancer in the U. S. received hypofractionated regimens, indicating a substantial adoption rate in this patient cohort. This widespread acceptance is further supported by clinical evidence.

Key Market Players

  • Siemens Healthineers AG
  • Accuray Incorporated
  • Elekta GmbH
  • Iba LLC
  • Hitachi, Ltd.
  • Mevion Medical Systems B.V.
  • Koninklijke Philips N.V.
  • Raysearch Laboratories AB
  • Brainlab AG
  • HD Biosciences Co., Ltd.

Report Scope:

In this report, the Global Intensity Modulated Radiotherapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intensity Modulated Radiotherapy Market, By Radiation Type:

  • Proton radiation
  • Electron radiation
  • Photon radiation
  • Carbon-lon radiation

Intensity Modulated Radiotherapy Market, By End User:

  • Hospital & Clinics
  • Ambulatory Surgical care
  • Others

Intensity Modulated Radiotherapy Market, By Application:

  • Prostate cancer
  • Lung cancer
  • Breast cancer
  • Brain cancer
  • Gynecological cancers
  • Gastrointestinal cancers
  • Other cancers

Intensity Modulated Radiotherapy Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Intensity Modulated Radiotherapy Market.

Available Customizations:

Global Intensity Modulated Radiotherapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Product Code: 22136

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intensity Modulated Radiotherapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Radiation Type (Proton radiation, Electron radiation, Photon radiation, Carbon-lon radiation)
    • 5.2.2. By End User (Hospital & Clinics, Ambulatory Surgical care, Others)
    • 5.2.3. By Application (Prostate cancer, Lung cancer, Breast cancer, Brain cancer, Gynecological cancers, Gastrointestinal cancers, Other cancers)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Intensity Modulated Radiotherapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Radiation Type
    • 6.2.2. By End User
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Intensity Modulated Radiotherapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Radiation Type
        • 6.3.1.2.2. By End User
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Intensity Modulated Radiotherapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Radiation Type
        • 6.3.2.2.2. By End User
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Intensity Modulated Radiotherapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Radiation Type
        • 6.3.3.2.2. By End User
        • 6.3.3.2.3. By Application

7. Europe Intensity Modulated Radiotherapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Radiation Type
    • 7.2.2. By End User
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Intensity Modulated Radiotherapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Radiation Type
        • 7.3.1.2.2. By End User
        • 7.3.1.2.3. By Application
    • 7.3.2. France Intensity Modulated Radiotherapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Radiation Type
        • 7.3.2.2.2. By End User
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Intensity Modulated Radiotherapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Radiation Type
        • 7.3.3.2.2. By End User
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Intensity Modulated Radiotherapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Radiation Type
        • 7.3.4.2.2. By End User
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Intensity Modulated Radiotherapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Radiation Type
        • 7.3.5.2.2. By End User
        • 7.3.5.2.3. By Application

8. Asia Pacific Intensity Modulated Radiotherapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Radiation Type
    • 8.2.2. By End User
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Intensity Modulated Radiotherapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Radiation Type
        • 8.3.1.2.2. By End User
        • 8.3.1.2.3. By Application
    • 8.3.2. India Intensity Modulated Radiotherapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Radiation Type
        • 8.3.2.2.2. By End User
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Intensity Modulated Radiotherapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Radiation Type
        • 8.3.3.2.2. By End User
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Intensity Modulated Radiotherapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Radiation Type
        • 8.3.4.2.2. By End User
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Intensity Modulated Radiotherapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Radiation Type
        • 8.3.5.2.2. By End User
        • 8.3.5.2.3. By Application

9. Middle East & Africa Intensity Modulated Radiotherapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Radiation Type
    • 9.2.2. By End User
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Intensity Modulated Radiotherapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Radiation Type
        • 9.3.1.2.2. By End User
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Intensity Modulated Radiotherapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Radiation Type
        • 9.3.2.2.2. By End User
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Intensity Modulated Radiotherapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Radiation Type
        • 9.3.3.2.2. By End User
        • 9.3.3.2.3. By Application

10. South America Intensity Modulated Radiotherapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Radiation Type
    • 10.2.2. By End User
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Intensity Modulated Radiotherapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Radiation Type
        • 10.3.1.2.2. By End User
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Intensity Modulated Radiotherapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Radiation Type
        • 10.3.2.2.2. By End User
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Intensity Modulated Radiotherapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Radiation Type
        • 10.3.3.2.2. By End User
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Intensity Modulated Radiotherapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Siemens Healthineers AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Accuray Incorporated
  • 15.3. Elekta GmbH
  • 15.4. Iba LLC
  • 15.5. Hitachi, Ltd.
  • 15.6. Mevion Medical Systems B.V.
  • 15.7. Koninklijke Philips N.V.
  • 15.8. Raysearch Laboratories AB
  • 15.9. Brainlab AG
  • 15.10. HD Biosciences Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!